Type2diabetes: Clinical Trials

3 trials for Type2diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Type2diabetes: new trials by email Literature Review of Type2diabetes trials Research Report on Type2diabetes

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
Dorzagliatin tablets - Type2diabetes
Phase 4CompletedHua Medicine Limited20242024-01-172026-07-10
Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DM
Henagliflozin, Continuous Subcutaneous Insulin Infusion - Type2diabetes
Phase 4CompletedFirst Affiliated Hospital of Guangxi Medical University2102023-03-012025-03-12
Efficacy and Safety of Dapagliflozin for the Hospital Management of Patients With Type 2 Diabetes
Dapagliflozin, Glargine - Type2diabetes, Coronary Artery Disease
Phase 4CompletedMedanta, The Medicity, India2502022-07-292023-10-19

Narrower conditions

Coronary Artery Disease (1)  ·  Diabetes Mellitus, Type 2 (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Disease (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Heart Diseases (1)  ·  Metabolic Diseases (1)  ·  Myocardial Ischemia (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Vascular Diseases (1)

Interventions

Dorzagliatin (1)  ·  Insulin Glargine (1)  ·  Insulin Lispro (1)  ·  dapagliflozin (1)  ·  henagliflozin (1)

Sponsors

First Affiliated Hospital of Guangxi Medical University (1)  ·  Hua Medicine Limited (1)  ·  Medanta, The Medicity, India (1)

Countries

China (2)  ·  India (1)

Results publications

PMID 31912605, PMID 37380728, PMID 39395826, PMID 41853855